Evidence map›Paper›PMID 22015718›Full record

ArticleDevelopmental biology2011

PI3K/mTOR signaling regulates prostatic branching morphogenesis.

Susmita Ghosh, Hiu Lau, Brian W Simons, Jonathan D Powell, David J Meyers, Angelo M De Marzo, David M Berman, Tamara L Lotan

Abstract read
In one paragraph

Article in Developmental biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Prostate Organogenesis.Cold Spring Harbor perspectives in medicine · 2018
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Susmita GhoshDepartment of Pathology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.
Hiu Lau
Brian W Simons
Jonathan D Powell
David J Meyers
Angelo M De Marzo
David M Berman
Tamara L Lotan
Johns Hopkins University · US

Funding

A central role for mTOR in Determining T Cell Activation versus ToleranceR01AI077610 · NIAID · JOHNS HOPKINS UNIVERSITY · PI POWELL, JONATHAN D · 2009 to 2019
$4.0M
Spatiotemporal Modulation of PIP[3]Signaling in Prostatic TubulogenesisK08DK088769 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI LOTAN, TAMARA LEVIN · 2010 to 2014
$781k
NIAID NIH HHS R01 AI077610NIDDK NIH HHS K08 DK088769
6 · The paper itself

Abstract

Prostatic branching morphogenesis is an intricate event requiring precise temporal and spatial integration of numerous hormonal and growth factor-regulated inputs, yet relatively little is known about the downstream signaling pathways that orchestrate this process. In this study, we use a novel mesenchyme-free embryonic prostate culture system, newly available mTOR inhibitors and a conditional PTEN loss-of-function model to investigate the role of the interconnected PI3K and mTOR signaling pathways in prostatic organogenesis. We demonstrate that PI3K levels and PI3K/mTOR activity are robustly induced by androgen during murine prostatic development and that PI3K/mTOR signaling is necessary for prostatic epithelial bud invasion of surrounding mesenchyme. To elucidate the cellular mechanism by which PI3K/mTOR signaling regulates prostatic branching, we show that PI3K/mTOR inhibition does not significantly alter epithelial proliferation or apoptosis, but rather decreases the efficiency and speed with which the developing prostatic epithelial cells migrate. Using mTOR kinase inhibitors to tease out the independent effects of mTOR signaling downstream of PI3K, we find that simultaneous inhibition of mTORC1 and mTORC2 activity attenuates prostatic branching and is sufficient to phenocopy combined PI3K/mTOR inhibition. Surprisingly, however, mTORC1 inhibition alone has the reverse effect, increasing the number and length of prostatic branches. Finally, simultaneous activation of PI3K and downstream mTORC1/C2 via epithelial PTEN loss-of-function also results in decreased budding reversible by mTORC1 inhibition, suggesting that the effect of mTORC1 on branching is not primarily mediated by negative feedback on PI3K/mTORC2 signaling. Taken together, our data point to an important role for PI3K/mTOR signaling in prostatic epithelial invasion and migration and implicates the balance of PI3K and downstream mTORC1/C2 activity as a critical regulator of prostatic epithelial morphogenesis.

Indexed as

Signal TransductionAnimalsApoptosisCell ProliferationEpithelial CellsFemaleFluorescent Antibody TechniqueMaleMechanistic Target of Rapamycin Complex 1MiceMice, Inbred C57BLMorphogenesisMultiprotein ComplexesPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsPhosphorylationCrtc2 protein, mouseMechanistic Target of Rapamycin Complex 1mTOR protein, mouseMultiprotein ComplexesPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsProteinsPTEN PhosphohydrolaseTOR Serine-Threonine KinasesTrans-ActivatorsTranscription Factors

Identifiers

PMID22015718
PMCPMC3225010
OpenAlexW2029777184

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.